Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Cancer of Ovary

vidarabine has been researched along with Cancer of Ovary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L; Zou, W1
Kay, BK; Koduvayur, SP; Lavie, A; Su, Y1
Galaup, A; Paci, A1
Champlin, RE; Donato, ML; Gershenson, DM; Levenback, C; McMeekin, S1
Cao, Z; Chen, YC; Fang, J; Jiang, BH; Reed, E1
De Marco, C; Gornati, D; Orlandi, L; Silvestrini, R; Vaglini, M; Zaffaroni, N1

Reviews

1 review(s) available for vidarabine and Cancer of Ovary

ArticleYear
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:3

    Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Myeloablative Agonists; Ovarian Neoplasms; Vidarabine; Whole-Body Irradiation

2013

Other Studies

5 other study(ies) available for vidarabine and Cancer of Ovary

ArticleYear
Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
    Molecular medicine reports, 2015, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Bevacizumab; Cell Adhesion; Cell Line, Tumor; Cell Movement; Disease Progression; Drug Synergism; Female; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Neoplasm Invasiveness; Ovarian Neoplasms; Signal Transduction; Vidarabine

2015
Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Deoxycytidine Kinase; Drug Delivery Systems; Female; Humans; Ovarian Neoplasms; Phosphorylation; Receptor, ErbB-2; Tumor Cells, Cultured; Vidarabine

2016
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.
    Gynecologic oncology, 2004, Volume: 92, Issue:1

    Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Resistance, Neoplasm; Female; Graft vs Tumor Effect; Humans; Melphalan; Ovarian Neoplasms; Vidarabine

2004
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.
    Molecular pharmacology, 2004, Volume: 66, Issue:1

    Topics: Antineoplastic Agents; Aryl Hydrocarbon Receptor Nuclear Translocator; DNA-Binding Proteins; Enzyme Activation; Female; Gene Expression; Gene Silencing; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Aryl Hydrocarbon; RNA, Messenger; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vascular Endothelial Growth Factors; Vidarabine

2004
Fludarabine as a modulator of cisplatin activity in human tumour primary cultures and established cell lines.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:10

    Topics: Antineoplastic Agents; Cisplatin; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Melanoma; Ovarian Neoplasms; Tumor Cells, Cultured; Vidarabine

1996